4967.T
4967.T
JP3301100008
KOBAYASHI PHARMACEUTICALS
Loading chart...

Company Profile

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, paper products, and hand warmers; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, sales promotion and market research, promotional goods production and sales, and asset management activities, as well as in pharmacy, retail, and cleaning industries. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Related stocks

4912.T
4912.T • Japan
LION CORP
1,768.5 JPY
3.09B USD 1Y +14.5%
4922.T
4922.T • Japan
KOSE HLDGS CORP
5,514 JPY
1.98B USD 1Y -5.5%
4927.T
4927.T • Japan
POLA ORBIS HOLDINGS INC
1,380.5 JPY
1.93B USD 1Y +4%
7956.T
7956.T • Japan
PIGEON CORP
2,099 JPY
1.58B USD 1Y +18.8%
8283.T
8283.T • Japan
PALTAC CORP
6,630 JPY
2.54B USD
7806.T
7806.T • Japan
MTG CO LTD
9,150 JPY
2.27B USD 1Y +121.3%
UNVR.JK
UNVR.JK • Indonesia
Unilever Indonesia Tbk
1,595 IDR
3.39B USD 1Y -16.7%
4527.T
4527.T • Japan
ROHTO PHARMACEUTICAL CO
2,693 JPY
3.84B USD 1Y +9.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
25.3% p.a.
Max Drawdown (5Y)
-53.1%
Sharpe Ratio (5Y)
-0.25
Beta Factor
0.20
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 329.7 (Elevated multiple compression risk)
Historical Stress Test: Maximum peak-to-trough drawdown of -62.1% in the extended horizon.
ende